Innoviva, Inc.
INVA
$20.92
$0.040.19%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 18.10% | 5.26% | |||
| Total Other Revenue | 10.51% | -7.54% | |||
| Total Revenue | 13.15% | -3.46% | |||
| Cost of Revenue | 42.94% | -31.00% | |||
| Gross Profit | 8.03% | 3.65% | |||
| SG&A Expenses | -3.92% | -12.24% | |||
| Depreciation & Amortization | 1.11% | -0.55% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 9.74% | 0.03% | |||
| Operating Income | 16.99% | -7.10% | |||
| Income Before Tax | 288.13% | -256.27% | |||
| Income Tax Expenses | 11.44% | 83.29% | |||
| Earnings from Continuing Operations | 236.72% | -329.12% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 236.72% | -329.12% | |||
| EBIT | 16.99% | -7.10% | |||
| EBITDA | 14.84% | -6.26% | |||
| EPS Basic | 236.37% | -328.80% | |||
| Normalized Basic EPS | 18.80% | -12.07% | |||
| EPS Diluted | 204.01% | -363.81% | |||
| Normalized Diluted EPS | -11.57% | 18.21% | |||
| Average Basic Shares Outstanding | 0.25% | 0.13% | |||
| Average Diluted Shares Outstanding | 34.67% | -25.52% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||